Case Study: Guillain-Barre Syndrome in a Patient with Severe COVID-19
source: pixabay.com

Case Study: Guillain-Barre Syndrome in a Patient with Severe COVID-19

In a case study published on dovepress.com, a 17 year old girl diagnosed with COVID-19 developed Guillain-Barre syndrome, a neurological disease causing muscle weakness, as her symptoms progressed. While COVID-19…

Continue Reading Case Study: Guillain-Barre Syndrome in a Patient with Severe COVID-19
LX1001 for APOE4-Associated Alzheimer’s Granted Fast Track Designation
Thor_Deichmann / Pixabay

LX1001 for APOE4-Associated Alzheimer’s Granted Fast Track Designation

  In a recent press release, biotechnology and gene therapy company LEXEO Therapeutics ("LEXEO") shared that its gene therapy LX1001 received Fast Track designation from the FDA. Overall, LX1001 is…

Continue Reading LX1001 for APOE4-Associated Alzheimer’s Granted Fast Track Designation